1. Home
  2. PEBO vs TSHA Comparison

PEBO vs TSHA Comparison

Compare PEBO & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peoples Bancorp Inc.

PEBO

Peoples Bancorp Inc.

N/A

Current Price

$38.46

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

N/A

Current Price

$4.12

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PEBO
TSHA
Founded
1902
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
PEBO
TSHA
Price
$38.46
$4.12
Analyst Decision
Hold
Strong Buy
Analyst Count
7
13
Target Price
★ $42.83
$13.00
AVG Volume (30 Days)
395.3K
★ 3.2M
Earning Date
10-20-2026
11-12-2026
Dividend Yield
★ 4.39%
N/A
EPS Growth
N/A
★ 5.56
EPS
★ 2.49
N/A
Revenue
$197,000.00
★ $9,773,000.00
Revenue This Year
$7.15
N/A
Revenue Next Year
$55.89
$783.47
P/E Ratio
$15.34
★ N/A
Revenue Growth
N/A
★ 17.28
52 Week Low
$28.23
$3.46
52 Week High
$42.29
$7.30

Technical Indicators

Market Signals
Indicator
PEBO
TSHA
Relative Strength Index (RSI) 50.91 43.88
Support Level $37.53 $3.92
Resistance Level $39.33 $4.59
Average True Range (ATR) 0.81 0.29
MACD -0.03 0.04
Stochastic Oscillator 17.26 24.59

Price Performance

Historical Comparison
PEBO
TSHA

About PEBO Peoples Bancorp Inc.

Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Share on Social Networks: